Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy

NCT00903656 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped Caelyx was not available anymore

Conditions

Metastatic Breast Cancer

Interventions

DRUG: doxorubicinhydrochloride, Lapatinib

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie

Collaborators

[object Object]